Nomogram Based on Monocyte-to-Lymphocyte Ratio to Predict Survival of Unresectable Esophageal Squamous Cell Carcinoma Who Receive First-Line PD-1/PD-L1 Inhibitors Combined with Chemotherapy

Nomogram Based on Monocyte-to-Lymphocyte Ratio to Predict Survival of Unresectable Esophageal Squamous Cell Carcinoma Who Receive First-Line PD-1/PD-L1 Inhibitors Combined with Chemotherapy

Background. Chemoimmunotherapy has become the first-line treatment for unresectable esophageal squamous cell carcinoma (ESCC). Still, reliable biomarkers to identify patients who could benefit from this combined therapy remain uncertain. This study focused on elucidating the predictive significance...

Full description

Bibliographic Details
Main Authors: Xiaolu Ma, Yongfeng Ding, Jiong Qian, Mingyu Wan, Ning Li, Chenyu Mao, Cheng Xiao, Haiping Jiang, Yulong Zheng, Luntao Wu, Xiaoyu Chen, Nong Xu
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Current Oncology
Subjects:
esophageal squamous cell carcinoma
PD-1/PD-L1
immunotherapy
monocyte-to-lymphocyte ratio
nomogram
Online Access:https://www.mdpi.com/1718-7729/29/11/702

Internet

https://www.mdpi.com/1718-7729/29/11/702

Similar Items